Azenta, Inc. (AZTA)
32.88
-4.52
(-12.09%)
USD |
NASDAQ |
Aug 24, 16:00
32.88
0.00 (0.00%)
After-Hours: 20:00
Azenta EPS Diluted (Quarterly) : 0.0542 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0542 |
| March 31, 2026 | -3.491 |
| December 31, 2025 | -0.336 |
| September 30, 2025 | 1.106 |
| June 30, 2025 | -1.048 |
| March 31, 2025 | -1.042 |
| December 31, 2024 | -0.2409 |
| September 30, 2024 | -0.1381 |
| June 30, 2024 | -0.1243 |
| March 31, 2024 | -2.469 |
| December 31, 2023 | -0.2773 |
| September 30, 2023 | 0.0565 |
| June 30, 2023 | -0.0388 |
| March 31, 2023 | -0.0713 |
| December 31, 2022 | -0.1549 |
| September 30, 2022 | -0.296 |
| June 30, 2022 | -0.1144 |
| March 31, 2022 | -5.891 |
| December 31, 2021 | 0.5786 |
| September 30, 2021 | 0.2925 |
| June 30, 2021 | 0.5272 |
| March 31, 2021 | 0.3198 |
| December 31, 2020 | 0.3504 |
| September 30, 2020 | 0.3915 |
| June 30, 2020 | 0.1854 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1237 |
| December 31, 2019 | 0.1773 |
| September 30, 2019 | 0.056 |
| June 30, 2019 | 0.1001 |
| March 31, 2019 | 0.0473 |
| December 31, 2018 | 0.1998 |
| September 30, 2018 | 0.1456 |
| June 30, 2018 | 0.3201 |
| March 31, 2018 | 0.9491 |
| December 31, 2017 | 0.2326 |
| September 30, 2017 | 0.25 |
| June 30, 2017 | 0.25 |
| March 31, 2017 | 0.20 |
| December 31, 2016 | 0.20 |
| September 30, 2016 | 0.15 |
| June 30, 2016 | 0.12 |
| March 31, 2016 | -1.22 |
| December 31, 2015 | -0.07 |
| September 30, 2015 | 0.10 |
| June 30, 2015 | 0.11 |
| March 31, 2015 | 0.04 |
| December 31, 2014 | -0.04 |
| September 30, 2014 | 0.0036 |
| June 30, 2014 | -0.0363 |
| March 31, 2014 | 0.05 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 1.198 |
| Bio-Rad Laboratories, Inc. | 13.85 |
| Bruker Corp. | -0.413 |
| Danaher Corp. | 1.230 |
| Harvard Bioscience, Inc. | -0.643 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.529M |
| Revenue (Quarterly) | 161.18M |
| Total Expenses (Quarterly) | 162.71M |
| Enterprise Value | 1.165B |
| Gross Profit Margin (Quarterly) | 44.89% |
| Profit Margin (Quarterly) | -0.95% |
| Earnings Yield | -8.11% |
| Normalized Earnings Yield | -0.7327 |